• Cycloheximide: Protein Biosynthesis Inhibitor for Apoptosis

  2026-08-04

  Cycloheximide from APExBIO unlocks precise control in protein turnover and apoptosis assays, enabling high-resolution dissection of cell fate mechanisms. This guide delivers actionable workflows, optimization strategies, and unique translational insights for leveraging this gold-standard protein biosynthesis inhibitor in advanced research.

• LMO2/LDB1 Complex Drives AML Progression: Mechanistic Insigh

  2026-08-04

  This study delineates the oncogenic role of the LMO2/LDB1 transcriptional complex in acute myeloid leukemia (AML), revealing that their interaction is crucial for leukemic cell proliferation and survival. The findings highlight the complex as a promising molecular target, with implications for developing novel therapeutic strategies in AML.

• CBD Attenuates Orofacial Pain via Endocannabinoid Modulation

  2026-08-03

  This study demonstrates that cannabidiol (CBD) significantly reduces both sensory and affective components of orofacial inflammatory pain in mice. Through a multidimensional approach, the research elucidates how CBD modulates peripheral and central endocannabinoid pathways, highlighting its translational potential for comprehensive pain management.

• GPR107 Deficiency Amplifies Diabetic Nephropathy via AT1R/Ca

  2026-08-03

  Xu et al. uncover a mechanistic link between GPR107 deficiency, impaired AT1R endocytosis, and exacerbated collagen type IV accumulation in diabetic nephropathy. Their findings highlight how altered calcium signaling in podocytes drives glomerular basement membrane thickening, presenting GPR107 as a potential therapeutic target.

• Rimonabant (SR141716): Reliable CB1 Antagonist for Lab Assay

  2026-08-02

  This authoritative article addresses core experimental challenges in cell viability, appetite regulation, and cannabinoid withdrawal research, demonstrating how 'Rimonabant (SR141716)' (SKU B1429) supports data reliability and workflow reproducibility. Through scenario-driven Q&A, bench scientists gain actionable protocols and evidence-backed guidance tailored to endocannabinoid system modulation.

• TCF25 Orchestrates Lysosomal Acidification Under Glucose Sta

  2026-08-01

  Ren et al. identify TCF25 as a nutrient sensor that regulates lysosomal acidification via V-ATPase, coordinating metabolic adaptation and cell death during glucose deprivation. This work elucidates a direct mechanistic link between transcriptional regulation, endolysosomal pH control, and ferroptosis-like lysosomal cell death, with implications for targeting metabolic stress responses in disease.

• 5-Ethynyl-2'-deoxyuridine: Precision Cell Proliferation Assa

  2026-07-31

  5-Ethynyl-2'-deoxyuridine (5-EdU) streamlines cell proliferation detection with unmatched speed and preservation of morphology, setting a new gold standard for S phase DNA synthesis assays. This article delivers actionable workflows, troubleshooting tactics, and experimental insights for tissue regeneration and tumor growth research.

• Haloprogin: Broad-Spectrum Antifungal and Antimicrobial Insi

  2026-07-31

  The landmark 1970 study established Haloprogin as a potent topical antifungal agent with unique activity against dermatophytes, Candida species, and Gram-positive bacteria. Its comparative evaluation with tolnaftate revealed broader antimicrobial coverage, influencing modern research protocols for dermatophytosis and Candida infection models.

• Molidustat (BAY85-3934): Protocols and Troubleshooting for H

  2026-07-30

  Molidustat (BAY85-3934) offers precise, tunable stabilization of hypoxia-inducible factors, enabling robust erythropoietin pathway modeling and next-generation renal anemia research. This guide details validated experimental workflows, troubleshooting, and protocol enhancements for maximizing data integrity and translational impact.

• Scenario-Driven Optimization with Lumiracoxib (SKU B1458)

  2026-07-30

  This article delivers scenario-based guidance for leveraging Lumiracoxib (SKU B1458), a highly selective COX-2 inhibitor, to overcome common laboratory challenges in cell viability, cytotoxicity, and muscle regeneration assays. Drawing from literature and product data, it equips researchers with actionable strategies to enhance reproducibility, interpret complex results, and choose reliable reagents for inflammation and angiogenesis studies.

• PDK4-IN-1 Hydrochloride: Precision PDK4 Inhibitor in Metabol

  2026-07-29

  PDK4-IN-1 hydrochloride enables rigorous dissection of mitochondrial energy metabolism and PDH pathway regulation with nanomolar selectivity. This guide translates bench research and reference breakthroughs into actionable protocols, advanced troubleshooting, and real-world applications for metabolic, cardiac, and tumor models.

• EV-Transferred ACLY Drives Macrophage Reprogramming in Liver

  2026-07-29

  This study reveals that hepatocellular carcinoma (HCC) cells secrete extracellular vesicles carrying ATP-citrate lyase (ACLY), which, upon uptake by monocytes, induce their transformation into immunosuppressive tumor-associated macrophages (TAMs). These findings expose a previously unrecognized metabolic axis in tumor immune evasion, highlighting novel therapeutic opportunities for enhancing immunotherapy in liver cancer.

• NSC23766 Trihydrochloride: Decoding Rac1 Inhibition in Immun

  2026-07-28

  Explore how the Rac GTPase inhibitor NSC-23766 enables advanced dissection of Rac1-driven immune evasion and apoptosis in cancer. This article offers a unique, mechanistic bridge between CD47-SIRPα signaling and practical Rac1 pathway targeting strategies for research.

• Vidarabine Monohydrate: Applied Antiviral Workflows & Optimi

  2026-07-28

  Vidarabine monohydrate, a high-purity nucleoside analog from APExBIO, empowers robust, reproducible inhibition of viral DNA synthesis in advanced virology research. This guide details streamlined workflows, troubleshooting strategies, and comparative advantages for applied antiviral and model development.

• TCF25 Regulates Lysosomal Cell Death Under Glucose Starvatio

  2026-07-27

  Ren et al. identify TCF25 as a nutrient sensor orchestrating metabolic adaptation and lysosome-dependent cell death under glucose starvation, through modulation of V-ATPase and ferritinophagy. This study expands understanding of how cells balance survival and death during metabolic stress, opening avenues for targeting lysosomal pathways in disease.

451 records 9/31 page Previous Next First page 上5页 678910 下5页 Last page